(VIANEWS) – NAVAMEDIC (NAVA.OL), SPAREBANKEN SØR (SOR.OL), SPBK1 HELGELAND (HELG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NAVAMEDIC (NAVA.OL)
72.2% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr-1.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.6%, now sitting on 382.14M for the twelve trailing months.
Volume
Today’s last reported volume for NAVAMEDIC is 263 which is 98.92% below its average volume of 24467.
More news about NAVAMEDIC.
2. SPAREBANKEN SØR (SOR.OL)
31.1% sales growth and 8.36% return on equity
Sparebanken Sør operates as an independent financial institution in Norway. It operates through two segments, Retail Market and Corporate Market. The company is involved in banking, securities trading, and real estate brokerage activities in Agder, Rogaland, Vestfold, and Telemark counties. It also provides leasing, mortgage, and property management services; and sells general insurance, occupational pension, and group life insurance products. The company was founded in 1824 and is headquartered in Kristiansand, Norway. Sparebanken Sør operates as a subsidiary of Sparebankstiftelsen Sparebanken Sør.
Earnings Per Share
As for profitability, SPAREBANKEN SØR has a trailing twelve months EPS of kr11.3.
PE Ratio
SPAREBANKEN SØR has a trailing twelve months price to earnings ratio of 11.15. Meaning, the purchaser of the share is investing kr11.15 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.36%.
More news about SPAREBANKEN SØR.
3. SPBK1 HELGELAND (HELG.OL)
28.7% sales growth and 9.31% return on equity
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr12.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 10.5. Meaning, the purchaser of the share is investing kr10.5 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 23.3% and 84%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 10.26 and the estimated forward annual dividend yield is 7.77%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 79.2%, now sitting on 959M for the twelve trailing months.
More news about SPBK1 HELGELAND.
4. ITERA (ITERA.OL)
11.2% sales growth and 138.07% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.59.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 22.03. Meaning, the purchaser of the share is investing kr22.03 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 138.07%.
Yearly Top and Bottom Value
ITERA’s stock is valued at kr13.00 at 12:20 EST, way below its 52-week high of kr14.50 and way above its 52-week low of kr10.50.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.5%, now sitting on 735.84M for the twelve trailing months.
More news about ITERA.
5. MBWS (MBWS.PA)
8.6% sales growth and 3.81% return on equity
Marie Brizard Wine & Spirits SA engages in the producing, marketing, and selling wines and spirits in Western Europe, the Middle East, Africa, Central and Eastern Europe, the Americas, and Asia-Pacific. It primarily offers scotch whisky under the William Peel brand; vodka under the Sobieski and Krupnik brands; wine-based beverages under the Fruits and Wine brand name; liqueurs and syrups under the Marie Brizard brand; and cognac under the Cognac Gautier brand. The company was founded in 1755 and is based in Charenton-le-Pont, France. Marie Brizard Wine & Spirits SA operates as a subsidiary of Compagnie Financiere Europeenne De Prises De Participation SA.
Earnings Per Share
As for profitability, MBWS has a trailing twelve months EPS of €-0.863.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.81%.
More news about MBWS.
